# FDA Inspection 1224904 - Los Angeles Reproductive Center - December 12, 2023

Source: https://www.keypedia.com/records/fda_inspections/los-angeles-reproductive-center/f289edfe-565a-4161-9656-1480a6dc60cb
Source feed: FDA_Inspections

> FDA Inspection 1224904 for Los Angeles Reproductive Center on December 12, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1224904
- Company Name: Los Angeles Reproductive Center
- Inspection Date: 2023-12-12
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1224904 - 2023-12-12](https://www.keypedia.com/records/fda_inspections/los-angeles-reproductive-center/ef3e5234-0ab6-49f9-a089-74c5478ff275)
- [FDA Inspection 1072891 - 2018-10-17](https://www.keypedia.com/records/fda_inspections/los-angeles-reproductive-center/71b09320-56d7-43e5-842a-1420f7b98006)
- [FDA Inspection 1072891 - 2018-10-17](https://www.keypedia.com/records/fda_inspections/los-angeles-reproductive-center/20adab8c-8e19-45b2-992b-a2104daa1ed1)

Company: https://www.keypedia.com/companies/los-angeles-reproductive-center/2c49f625-b98c-4591-afcd-68104865436e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d